Viropharma News (NASDAQ:VPHM)
| Latest Viropharma News Headlines | | Date | Time | Source | | | 10/01/2008 | 9:41AM | PRNUS | ViroPharma to Present at Three October Healthcare Conferences
EXTON, Pa., Oct. 1 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the third annual JMP Securities Healthcare Focus Conference at 2:30 P.M. ET on Monday, October 6, 2008. The conference is being... More...>> |
| 09/03/2008 | 9:10AM | PRNUS | ViroPharma and Lev Receive Hart-Scott-Rodino Clearance from The Federal Trade Commission
EXTON, Pa., Sept. 3 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) and Lev Pharmaceuticals, Inc. (OTC:LEVP) (BULLETIN BOARD: LEVP) today announced that the waiting period required under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act has expired in connection with ViroPharma's proposed acquisition... More...>> |
| 08/28/2008 | 2:00PM | PRNUS | ViroPharma to Present at Three September Healthcare Conferences
EXTON, Pa., Aug. 28 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Thomas Weisel Partners 2008 Healthcare Conference at 8:00 A.M. ET on Thursday, September 4, 2008. The conference is being held... More...>> |
| 07/30/2008 | 7:46AM | PRNUS | ViroPharma Incorporated Reports Second Quarter 2008 Financial Results
- Company Achieves Record Vancocin(R) Net Sales; Increases Full Year Guidance for 2008 -
EXTON, Pa., July 30 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) reported today its financial results for the second quarter and six-months ended June 30, 2008.
Key events since March 31, 2008 include:
Development:... More...>> |
| 07/15/2008 | 9:05AM | PRNUS | ViroPharma To Acquire Lev Pharmaceuticals
- Acquisition Adds Late Stage Product Targeting Life-threatening Hereditary Angioedema Disease with Limited Treatment Options -
EXTON, Pa., July 15 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) and Lev Pharmaceuticals, Inc. (OTC:LEVP) (BULLETIN BOARD: LEVP) today announced that the companies have... More...>> |
| 07/14/2008 | 4:30PM | PRNUS | ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
- Conference Call to Discuss Results to Be Held at 9:00 A.M. -
EXTON, Pa., July 14 /PRNewswire-FirstCall/ -- ViroPharma Incorporated's (NASDAQ:VPHM) second quarter financial results for 2008 are expected to be released on Wednesday, July 30, 2008 before the open of the U.S. financial markets.
The company will host... More...>> |
| 07/08/2008 | 9:00AM | PRNUS | ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestin
EXTON, Pa., July 8 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) has been informed by U.S. Food and Drug Administration (FDA) that the July 23, 2008 meeting of its Advisory Committee for Pharmaceutical Science and Clinical Pharmacology is not intended to discuss specifically ViroPharma's Vancocin(R... More...>> |
| 06/05/2008 | 9:20AM | PRNUS | Viropharma Comments On Upcoming FDA Advisory Committee Meeting
EXTON, Pa., June 5 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) notes that FDA has published a notice of a meeting of its Advisory Committee for Pharmaceutical Science and Clinical Pharmacology to be held on July 23, 2008. The Committee will address several issues at this meeting, including a discussion... More...>> |
| 06/03/2008 | 2:02PM | PRNUS | ViroPharma to Present at Two Upcoming Healthcare Conferences
EXTON, Pa., June 3 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Goldman Sachs 29th Annual Global Healthcare Conference at 4:00 P.M. PDT on Tuesday, June 10, 2008. The conference is being... More...>> |
| 06/02/2008 | 8:00AM | PRNUS | New Publication of Phase 2 Data Shows Maribavir Markedly Reduced the Rate of Cytomegalovirus Infection and Disease in Bone Marro
- Prevalent in Immunosuppressed Patients, Cytomegalovirus Infection and Disease is Associated with a Range of Life Threatening Complications -
EXTON, Pa., June 2 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced the publication of results of its previously described Phase 2 study showing... More...>> |
| 05/29/2008 | 8:00AM | PRNUS | ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
- Phase 3 Study in 681 Stem Cell Transplant Patients Represents First Pivotal Study on a New Antiviral CMV Therapy in Stem Cell Transplant in Over a Decade -
EXTON, Pa., May 29 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced that it completed enrollment in its pivotal Phase 3 study of... More...>> |
| 05/13/2008 | 10:25AM | PRNUS | ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
EXTON, Pa., May 13 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Seventh Annual JMP Securities Research Conference at 5:00 P.M. ET on Monday, May 19, 2008. The conference is being held at... More...>> |
| 04/30/2008 | 7:30AM | PRNUS | ViroPharma Incorporated Reports First Quarter 2008 Financial Results
EXTON, Pa., April 30 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) reported today its financial results for the first quarter ended March 31, 2008.
Key events since December 31, 2007 include:
Development:
-- Notified sites participating in Phase 3 study of Camvia(TM) (maribavir)
in stem... More...>> |
| 04/16/2008 | 6:02PM | PRNUS | ViroPharma Announces Discontinuation of HCV-796 Development
EXTON, Pa., April 16 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) announced today that ViroPharma and Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), have jointly discontinued the development of HCV-796 due to the previously announced safety issue that emerged in the ongoing Phase 2 trial in... More...>> |
| 04/14/2008 | 4:00PM | PRNUS | ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
- Conference Call to Discuss Results to Be Held at 9:00 A.M. -
EXTON, Pa., April 14 /PRNewswire-FirstCall/ -- ViroPharma Incorporated's (NASDAQ:VPHM) first quarter financial results for 2008 are expected to be released on Wednesday, April 30, 2008 before the open of the U.S. financial markets.
The company will host... More...>> |
| 03/13/2008 | 2:27PM | PRNUS | ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
EXTON, Pa., March 13 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced that Vincent Milano, chief financial officer and chief operating officer of ViroPharma, will present at the Cowen & Company 28th Annual Health Care Conference at 1:40 P.M. ET on Tuesday, March 18, 2008. The conference... More...>> |
| 02/28/2008 | 9:33AM | PRNUS | ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
EXTON, Pa., Feb. 28 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced it will present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference at 1:30 P.M. ET on Wednesday, March 5, 2008. The conference is being held at The W Hotel, in New York City.
ViroPharma's... More...>> |
| 02/27/2008 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on AIG, TXN, CAT, ADSK, and VPHM
CHICAGO, Feb. 27 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at
http://www.iotogo.com/s/022708B (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts cover... More...>> |
| 02/27/2008 | 7:30AM | PRNUS | ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
EXTON, Pa., Feb. 27 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) reported today its financial results for the fourth quarter and twelve months ended December 31, 2007.
Key events since September 30, 2007 include:
Development:
-- European Orphan Drug Designation received for Camvia(TM) (maribavir);... More...>> |
| 02/26/2008 | 4:30PM | PRNUS | Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
- Michel de Rosen to Continue as Chairman of the Board of Directors; Daniel B. Soland Promoted to Chief Operating Officer -
EXTON, Pa., Feb. 26 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) announced today that, effective March 31, 2008, Vincent J. Milano will succeed Michel de Rosen as president and... More...>> |
|
|
|